substance p has been researched along with pemirolast in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goromaru, T; Hirakawa, T; Itoh, Y; Nakano, H; Oishi, R; Sendo, T; Takasaki, S | 1 |
Egashira, N; Kawashiri, T; Kurobe, K; Matsushita, N; Oishi, R; Tatsushima, Y; Yano, T | 1 |
Egashira, N; Kawashiri, T; Oishi, R; Yano, T | 1 |
3 other study(ies) available for substance p and pemirolast
Article | Year |
---|---|
Pemirolast potently attenuates paclitaxel hypersensitivity reactions through inhibition of the release of sensory neuropeptides in rats.
Topics: Animals; Calcitonin Gene-Related Peptide; Dose-Response Relationship, Drug; Drug Hypersensitivity; Male; Neurokinin A; Neuropeptides; Paclitaxel; Pyridines; Pyrimidinones; Rats; Rats, Sprague-Dawley; Substance P | 2004 |
Pemirolast reduces cisplatin-induced kaolin intake in rats.
Topics: Animals; Antineoplastic Agents; Aprepitant; Biological Transport; Body Weight; Cisplatin; Dexamethasone; Eating; Kaolin; Male; Morpholines; Ondansetron; Pyridines; Pyrimidinones; Rats; Substance P | 2011 |
[Substance P in antitumor drug-induced adverse reactions].
Topics: Animals; Antineoplastic Agents; Carboplatin; Histamine Antagonists; Humans; Nausea; Neuropeptides; Paclitaxel; Pyridines; Pyrimidinones; Substance P; Vomiting | 2013 |